Печать
NALIDIXIC ACID SODIUM
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Печать
NALIDIXIC ACID SODIUM
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Description_x000D_
General description_x000D_
Chemical structure: quinolone_x000D_
Packaging_x000D_
1, 5, 25, 100 g in glass bottle_x000D_
Biochem/physiol Actions_x000D_
Nalidixic acid sodium salt is an inhibitor of bacterial DNA polymerase (DNA gyrase) and avian myeloblastoma virus reverse transcriptase. Inhibits nucleic acid and protein synthesis in Saccharomyces cerevisiae._x000D_
Features and Benefits_x000D_
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm._x000D_
This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®1280), a biologically annotated collection of high-quality, ready-to-screen compounds. Click here to learn more._x000D_
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here._x000D_
Legal Information_x000D_
LOPAC is a registered trademark of Sigma-Aldrich Co. LLC
Related Categories
Antibacterial, Antibiotics, Antibiotics A to Z, Antibiotics N-S, Antibiotics by Application, Antibiotics by Mechanism of Action, Apoptosis and Cell Cycle, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience, Chemical Structure Class, DNA Repair Regulators, DNA metabolism, Diversification Ready Pharma-Developed Compounds, Genetic Marker Selection, Inhibits an Enzyme, Interferes with DNA Synthesis, L - Z, N, Quinolones and Fluoroquinolones, Sanofi Aventis, Spectrum of ActivityMore... Quality Level
Дорогой клиент, на сайте внедрена нейросеть для сбора информации о товаре. Это может привести к незначительным расхождениям в характеристиках продукции.
